Seeking Alpha

Acorda Therapeutics (ACOR): Q4 EPS of $0.24 misses by $0.04. Revenue of $81.5M beats by $2.6M. (PR)

Acorda Therapeutics (ACOR): Q4 EPS of $0.24 misses by $0.04. Revenue of $81.5M beats by $2.6M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)